Skip to main content

Liver Diseases: Diagnosis

Question for Department of Health and Social Care

UIN 38525, tabled on 18 July 2022

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of patient care pathways for the early detection of liver disease in England by (a) region and (b) integrated care system.

Answered on

21 July 2022

No specific assessment has been made. However, in 2021, NHS England commissioned a stocktake of health inequalities in liver disease and the relevant care pathways, which recognised the association of regional variation with many risk factors, morbidity and mortality.

The Hepatobiliary Clinical Reference Group is reviewing the findings of this stocktake, which will inform priorities for action in 2022/23. NHS England is developing a policy on screening and treatment of patients commencing chemotherapy who may be unaware they are living with hepatitis B. The hepatitis C programme has reduced the prevalence of the disease through identifying patients in the community in a range of settings.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.
Interests declared
The Member has declared that they have interests which may be relevant to the subject matter of this question.